StonvexLoading…
StonvexStonvexStonvexCore line items from IPI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $298.33M | $254.69M | $279.08M |
Operating Income | $10.66M | $-19.86M | $-43.97M |
Net Income | $11.19M | $-212.84M | $-35.67M |
EPS (Diluted) | $0.85 | $-16.53 | $-2.80 |
Total Assets | $632.18M | $594.52M | $768.57M |
Total Liabilities | $140.75M | $120.13M | $84.14M |
Cash & Equivalents | $83.54M | $41.31M | $4.07M |
Free Cash Flow OCF − CapEx | $25.54M | $33.79M | $-21.83M |
Shares Outstanding | 13.13M | 12.91M | 12.81M |